e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge
Jessica K. Paulus, Kari E. Roberts
Source:
Eur Respir J 2013; 41: 1014-1016
Journal Issue:
May
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jessica K. Paulus, Kari E. Roberts. Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge. Eur Respir J 2013; 41: 1014-1016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research
Source: Eur Respir J, 50 (2) 1700983; 10.1183/13993003.00983-2017
Year: 2017
Leukotriene-mediated sex dimorphism in pulmonary arterial hypertensionmonocrotaline-induced rat.
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension
Source: Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018
Year: 2018
Sex matters in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 553-554
Year: 2014
Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model.
Source: International Congress 2017 – Experimental PH
Year: 2017
Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
Source: Eur Respir J, 53 (6) 1801524; 10.1183/13993003.01524-2018
Year: 2019
Autoimmunity and pulmonary arterial hypertension: The role of leptin
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Sex and haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 523-530
Year: 2013
Complexities of oestradiol pharmacology in pulmonary arterial hypertension
Source: Eur Respir J 2013; 41: 1466-1467
Year: 2013
Complexities of oestradiol pharmacology in pulmonary arterial hypertension
Source: Eur Respir J 2013; 41: 1465-1466
Year: 2013
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects
Source: Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016
Year: 2017
Sex differences in the relation between sex hormones and right ventricular function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Systemic consequences of pulmonary arterial hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019
The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept